We are live on ! Find out more
SK

Sarah Ketterer Causeway Capital Management

AUM $9.24B
1-Year Est. Return 21.27%
 

Sarah Ketterer is co-founder and CEO of Causeway Capital Management, a firm specializing in international and global value equities. Causeway is known for disciplined valuation work across developed and emerging markets. Ketterer’s commentary is often sought for perspective on non-U.S. equities, currencies, and relative value abroad.

This Fund
S&P 500
This Quarter Est. Return
+11.27%
1 Year Est. Return
+21.27%
3 Year Est. Return
+72.78%
5 Year Est. Return
+71.25%
10 Year Est. Return
+497.07%
AUM
$4.07B
AUM Growth
+$401M
Cap. Flow
+$68.7M
Cap. Flow %
1.69%
Top 10 Hldgs %
48.03%
Holding
105
New
15
Increased
43
Reduced
36
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 22.63%
2 Industrials 19.19%
3 Consumer Discretionary 13.17%
4 Financials 12.81%
5 Healthcare 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JLL icon
26
Jones Lang LaSalle
JLL
$17.8B
$49.8M 1.22%
184,742
-102,303
-36% -$24.8M
DEO icon
27
Diageo
DEO
$52.6B
$41.7M 1.02%
296,927
+60,861
+26% +$7.91M
PHG icon
28
Philips
PHG
$26.8B
$41.3M 1.02%
1,365,769
-27,788
-2% -$738K
SAP icon
29
SAP
SAP
$252B
$41M 1.01%
179,048
-28,679
-14% -$6.1M
QFIN icon
30
Qfin Holdings
QFIN
$1.41B
$40.9M 1.01%
1,373,338
+100,492
+8% +$2.29M
PUK icon
31
Prudential
PUK
$35B
$39.6M 0.97%
2,136,769
+40,010
+2% +$698K
BMY icon
32
Bristol-Myers Squibb
BMY
$137B
$38.8M 0.95%
750,455
+23,103
+3% +$1.08M
AZN icon
33
AstraZeneca
AZN
$257B
$38.2M 0.94%
245,220
+19,926
+9% +$3.22M
BP icon
34
BP
BP
$115B
$37.2M 0.91%
1,184,453
-131,306
-10% -$4.44M
GSK icon
35
GSK
GSK
$105B
$36.7M 0.9%
897,406
+143,871
+19% +$5.89M
CFG icon
36
Citizens Financial Group
CFG
$29.4B
$36.4M 0.9%
887,320
-428,417
-33% -$17.3M
STX icon
37
Seagate
STX
$193B
$36.2M 0.89%
330,110
-52,051
-14% -$5.32M
APTV icon
38
Aptiv
APTV
$10B
$34.1M 0.84%
472,889
+74,920
+19% +$5.23M
BUD icon
39
AB InBev
BUD
$155B
$33.7M 0.83%
508,607
+20,302
+4% +$1.25M
AXS icon
40
AXIS Capital
AXS
$7.2B
$32.4M 0.8%
+406,723
New +$30.5M
VIPS icon
41
Vipshop
VIPS
$6.98B
$29.8M 0.73%
1,896,196
-1,489,334
-44% -$19.9M
SNY icon
42
Sanofi
SNY
$110B
$28.7M 0.7%
497,482
+16,017
+3% +$865K
BTI icon
43
British American Tobacco
BTI
$121B
$27.6M 0.68%
754,901
+22,078
+3% +$789K
FINV
44
FinVolution Group
FINV
$1.03B
$26.9M 0.66%
4,345,275
+356,978
+9% +$1.9M
VEA icon
45
Vanguard FTSE Developed Markets ETF
VEA
$239B
$25.6M 0.63%
485,531
-178,618
-27% -$9.08M
MT icon
46
ArcelorMittal
MT
$54.4B
$24.8M 0.61%
946,245
+605,080
+177% +$13.9M
CNXC icon
47
Concentrix
CNXC
$1.55B
$22.2M 0.55%
433,254
-131,478
-23% -$8.8M
SHEL icon
48
Shell
SHEL
$257B
$22.1M 0.54%
335,634
-368,959
-52% -$26.1M
RELX icon
49
RELX
RELX
$62.6B
$20.1M 0.5%
424,410
-109,923
-21% -$5.1M
WB icon
50
Weibo
WB
$1.73B
$19.8M 0.49%
1,967,181
+66,781
+4% +$526K

Similar funds

Sarah Ketterer's Q3 2024 Portfolio in Review

As of Q3 2024, Sarah Ketterer held 105 positions worth $4.07B, up 11% from $3.67B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sarah Ketterer's Q3 2024 filing shows 15 new, 43 increased, 36 reduced and 8 closed positions. Its largest new stake was Smurfit Westrock: 4,197,579 shares worth $207M. The largest sale was Ryanair, an estimated $238M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Sarah Ketterer's largest Q3 2024 buy was Smurfit Westrock: 4,197,579 shares worth $207M.
  • Sarah Ketterer added most to Check Point Software Technologies in Q3 2024, an estimated $225M increase.
  • Sarah Ketterer's biggest Q3 2024 reduction was Ryanair, cutting an estimated $238M.
  • Sarah Ketterer fully exited Zebra Technologies in Q3 2024, selling an estimated $46.2M.
  • Sarah Ketterer's ten largest holdings make up 48% of its $4.07B portfolio in Q3 2024.
  • Sarah Ketterer opened 15 new positions and closed 8 in Q3 2024.
  • Sarah Ketterer's portfolio value rose 11% quarter-over-quarter to $4.07B.

Based on Causeway Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.